EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease

Hilla Chen iD, Gilad Segev iD, Michal Mazaki-Tovi iD

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.70063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Hilla Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel. Hauptthemen laut MEDLINE: Ergocalciferols, Proteinuria, Dog Diseases, Hyperparathyroidism, Secondary. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European College of Veterinary Internal Medicine - Companion Animals (ECVIM-CA) Clinical Studies Fund Purina Institute Resident Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal secondary hyperparathyroidism (RHPT) is an inevitable consequence of chronic kidney disease (CKD). Paricalcitol might safely attenuate RHPT and proteinuria. Hypothesis/Objective Paricalcitol decreases parathyroid hormone (PTH) and proteinuria in dogs with CKD. Animals Thirteen dogs with naturally acquired CKD.

Methods

Placebo-controlled clinical trial. Dogs were randomly allocated to receive a placebo or paricalcitol (14 ng/kg/day) in a crossover design of 2, 12-week arms. Dogs were evaluated every 3 weeks. Associations between treatment, visit, and the outcome variables were assessed using generalized estimating equations.

Results

PTH decreased by 22% (95% CI, 7%–35%, p = 0.006) in the paricalcitol-treated dogs and increased by 18% (95% CI, 2%–37%, p = 0.022) in the placebo-treated dogs with each visit. FGF-23 at 12 weeks increased compared with baseline in the paricalcitol-treated (mean 6941 pg/mL, 95% CI, 1781–20 057 vs. 489 pg/mL, 95% CI, 188–1272, p < 0.001, respectively), but not in the placebo-treated dogs (696 pg/mL, 95% CI, 316–1531 vs. 955 pg/mL, 95% CI, 308–2963, p = 0.529). Urine protein-to-creatinine ratio at 12 weeks increased compared with baseline in the placebo-treated (0.8, 95% CI, 0.3–1.3 vs. 0.5, 95% CI, 0.2–0.9, p = 0.04, respectively), but not in the paricalcitol-treated dogs (0.6, 95% CI, 0.3–0.9 vs. 1.0, 95% CI, 0.1–1.8, p = 0.35). Ionized calcium was unchanged between baseline and 12 weeks in the paricalcitol- and placebo-treated groups (1.3 mmol/L, 95% CI, 1.29–1.35 and 1.34, 95% CI, 1.27–1.40 vs. 1.30, 95% CI, 1.25–1.35, p = 0.12 and 1.28, 95% CI, 1.24–1.32, p = 0.034, respectively). However, 7/13 dogs developed mild hypercalcemia. Adverse effects were not reported by the owners. Conclusion and Clinical Importance Paricalcitol attenuated RHPT and stabilized renal proteinuria in dogs with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgocalciferolsProteinuriaDog DiseasesHyperparathyroidism, SecondaryRenal Insufficiency, ChronicAnimalsDogsFemaleMaleCross-Over StudiesParathyroid HormoneFibroblast Growth Factor-23Fibroblast Growth Factors

Stichwörter der Autor:innen

FGF‐23mineral bone disorderparathyroid hormonevitamin D

Substanzen

paricalcitolErgocalciferolsParathyroid HormoneFibroblast Growth Factor-23Fibroblast Growth Factors

Autor:innen und Institutionen

  • Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.

ORCID-Profile: Hilla Chen, Gilad Segev, Michal Mazaki-Tovi

Förderung

  • European College of Veterinary Internal Medicine - Companion Animals (ECVIM-CA) Clinical Studies Fund Purina Institute Resident Research Award

Zitieren

APA

Chen, H., Segev, G., & Mazaki-Tovi, M. (2025). Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70063

Vancouver

Chen H, Segev G, Mazaki-Tovi M. Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70063

BibTeX
@article{Chen2025,
  author = {Chen, Hilla and Segev, Gilad and Mazaki-Tovi, Michal},
  title = {Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.70063}
}
Kostenlos starten →